Stay updated with breaking news from Multimmune Gmb. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Data Bridge Market Research completed a qualitative study titled "Natural Killer (NK) Cell Therapeutics Market" with 100+ market data tables,...
Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For Natural Killer Cell Platform Therapy Worldwide February 04, 2021 11:35 ET | Source: Alphageneron Pharmaceuticals Alphageneron Pharmaceuticals Cambridge, Massachusetts, UNITED STATES CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc., (Alphageneron) signed an Exclusive License Agreement with Multimmune GmbH, of Munich, Germany, (Multimmune) on October 1 st, 2020, for its clinical stage autologous Natural Killer (“NK”) cel...
Press release content from Globe Newswire. The AP news staff was not involved in its creation. Alphageneron Pharmaceuticals Signed Exclusive License Agreement With Multimmune GmbH For ... Alphageneron PharmaceuticalsFebruary 4, 2021 GMT CAMBRIDGE, Mass., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc., (Alphageneron) signed an Exclusive License Agreement with Multimmune GmbH, of Munich, Germany, (Multimmune) on October 1st, 2020, for its clinical stage autologous Natural Killer (“NK”) cell therapy and companion diagnostic platform, for all fields worldwide. The autolo...